---
title: "ABH Healthcare Ltd (1286117) — Share Price, Financials & Analysis"
symbol: "1286117"
company: "ABH Healthcare Ltd"
canonical: "https://tapetide.com/stocks/1286117"
nse_symbol: "ABH"
sector: "Healthcare"
industry: "Healthcare Services"
generated_at: "2026-09-13T19:17:14.876Z"
---

# ABH Healthcare Ltd (1286117)

Canonical page: https://tapetide.com/stocks/1286117

## Company

- **NSE Symbol:** ABH
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Face Value:** ₹10
- **F&O Eligible:** No

## About

ABH Healthcare Ltd provides healthcare 
services and operates under the name 
Anil Baghi Hospital[1]

## Latest Price

- **Price:** ₹62.7
- **Change:** -3.25 (-4.93%)
- **Open:** ₹62.7
- **Day High:** ₹62.7
- **Day Low:** ₹62.7
- **Previous Close:** ₹65.95
- **Volume:** 43200
- **As Of:** 2026-09-11T09:46:43+00:00

## Key Insights

### Strengths

- Company has a good return on equity (ROE) track record: 3 Years ROE 37.2%

### Weaknesses

- Earnings include an other income of Rs.2.08 Cr.

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | 196% |
| revenue growth | 33% |

## Financial Statements

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- |
| Sales | 3.5 | 28.48 | 37.85 |
| Expenses | 3.28 | 25.36 | 32.09 |
| Operating Profit | 0.22 | 3.12 | 5.76 |
| OPM % | 6.29 | 10.96 | 15.22 |
| Other Income | 0 | 1.1 | 2.08 |
| Interest | 0 | 1.37 | 2.93 |
| Depreciation | 0 | 1.59 | 1.79 |
| Profit before tax | 0.22 | 1.26 | 3.12 |
| Tax % | 27.27 | 39.68 | 27.88 |
| Net Profit | 0.16 | 0.76 | 2.25 |
| EPS in Rs | 16 | 3.8 | 11.25 |
| Dividend Payout % | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- |
| Equity Capital | 0.1 | 2 | 2 |
| Reserves | 0.16 | 2.82 | 4.61 |
| Borrowings | 21.72 | 22.57 | 37.68 |
| Other Liabilities | 5.02 | 5.87 | 9.35 |
| Total Liabilities | 27 | 33.26 | 53.64 |
| Fixed Assets | 23.55 | 22.79 | 34.57 |
| CWIP | 0 | 0.63 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 3.45 | 9.84 | 19.07 |
| Total Assets | 27 | 33.26 | 53.64 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 |
| --- | --- | --- | --- |
| Debtor Days | 109.5 | 75.49 | 115.53 |
| Cash Conversion Cycle | 109.5 | 75.49 | 115.53 |
| Working Capital Days | -566.27 | -7.05 | 28.64 |
| ROCE % | — | 10.65 | 16.88 |

## Shareholding Pattern

### annual

| Category | Aug 2026 |
| --- | --- |
| Promoters | 69.99% |
| FIIs | 3% |
| Public | 27% |
| No. of Shareholders | 1124 |

### Quarterly

| Category | Aug 2026 |
| --- | --- |
| Promoters | 69.99% |
| FIIs | 3% |
| Public | 27% |
| No. of Shareholders | 1124 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Neutral
- **Buy / Neutral / Sell:** 0 / 19 / 0

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | — | Neutral |
| EMA (10) | — | Neutral |
| SMA (20) | — | Neutral |
| EMA (20) | — | Neutral |
| SMA (50) | — | Neutral |
| EMA (50) | — | Neutral |
| SMA (100) | — | Neutral |
| EMA (100) | — | Neutral |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | — | Neutral |
| MACD (12,26,9) | — | Neutral |
| Stochastic (14,3,3) | — | Neutral |
| ADX (14) | — | Neutral |
| Williams %R (14) | — | Neutral |
| ATR (14) | — | Neutral |
| ROC (12) | — | Neutral |
| Stoch RSI (14) | — | Neutral |
| UO (7,14,28) | — | Neutral |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:17:14.876Z.